Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer

International Journal of Gynecology and Obstetrics

Volumn 52, Issue 3, 1996, Pages 249-253

  Shushan, A ^a   Peretz, T ^a   Mor Yosef, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Breast cancer; GnRH agonist; Ovarian neoplasm; Tamoxifen

Indexed keywords

ANTIESTROGEN; CA 125 ANTIGEN; ESTRADIOL; GONADORELIN AGONIST; GONADOTROPIN; TAMOXIFEN; TRIPTORELIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; OVARY CYST; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0030070018     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(95)02590-1     Document Type: Article

References (22)

1. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989; 320: 479-484.
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15, 71-85.
3. Powles TJ, Jones AL, Ashley SE, O' Brien ME, Tidy VA, Treleavan J et al. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 1994; 31: 73-82.
4. Fentiman IS, Powles TJ. Tamoxifen and benign breast problems. Lancet 1987; ii: 1070-1077.
5. Weseley AC, Melnick H. Tamoxifen in clomiphene-resistant hypothalamic anovulation. Int J Fertil 1987; 32: 226-228.
6. Seoud MA-F, Johnson J, Weed JC Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993; 2: 165-169.
7. Jordan VC, Assikis VJ. Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynecol Obstet 1995; 49: 241-257.
8. Fornander T, Cedermark B, Mattsson A. Adjuvant tamoxifen in early breast cancer. Lancet 1989; i: 117-120.
9. Uziely B, Lewin A, Brufman G, Dorembus D, Mor-Yosef S. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993; 26: 101-105.
10. Jolies CJ, Smotkin D, Ford KL, Jones KP. Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report. J Reprod Med 1990; 35: 299-300.
11. Cohen I, Rosen DJD, Altaras M, Beyth Y. Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. Br J Cancer 1994; 69: 620-621.
12. Sawka CA, Pritchard KI, Paterson DJA, Thomsen DB, Shelley WE et al. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast cancer. Cancer Res 1986; 46: 3152-3156.
13. Barbieri RL, Ferracci AL, Droesch JN, Rochelson BL. Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer. Fertil Steril 1993; 59: 459-460.
14. Terada S, Uchide K, Suzuki N, Akasofu K. A follicular cyst during tamoxifen therapy in a premenopausal breast cancer woman. Gynecol Obstet Invest 1993; 35: 62-64.
15. Anteby E, Yagel S, Zacut D, Palti Z, Hochner-Celnikier D. Adverse effects of tamoxifen on the female genital tract. Harefuah 1993; 125: 267-270.
16. Shulman A, Cohen I, Altaras MM, Maymon R, Ben-Nun I, Tepper R et al. Ovarian cyst formation in two premenopausal patients treated with tamoxifen for breast cancer. Hum Reprod 1994; 9: 1427-1429.
17. Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol. In press.
18. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Morris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989; 161: 10-16.
19. Spicer DV, Pike MC, Henderson BE. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet 1991; 337: 1414.
20. Trope C. The preoperative diagnosis of malignancy of ovarian cysts. Neoplasia 1981; 28: 117.
21. Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991; 83: 1488-1491.
22. Latouche J, Crumeyrolle-Arias M, Jordan D et al. GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. Endocrinology 1989; 125: 1739-1741.